Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells
- 28 October 2010
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 296 (2), 216-224
- https://doi.org/10.1016/j.canlet.2010.04.008
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancerProceedings of the National Academy of Sciences of the United States of America, 2009
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer CellsCancer Research, 2009
- Epithelial-Mesenchymal Transition: A Cancer Researcher's Conceptual Friend and FoeThe American Journal of Pathology, 2009
- Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lungLaboratory Investigation, 2009
- Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell LinesPLOS ONE, 2009
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2Genes & Development, 2008
- Twist is a transcriptional repressor of E-cadherin gene expression in breast cancerBiochemical and Biophysical Research Communications, 2008
- Zeb1 links epithelial-mesenchymal transition and cellular senescenceDevelopment, 2008
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature, 2000